Principal Research Scientist II, Gastroenterology, Immunology Discovery Research
AbbVie
- Location
- Worcester, MA, United States
- Employment
- Full Time
- Work model
- On-Site
- Level
- Principal
- H-1B history
- 94 approvals (FY2023)
- Posted
- 1h ago
About this role
Company Description
About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
Job Description
Position Overview: AbbVie’s Immunology Discovery Research organization seeks an impactful scientific leader to manage pioneering research in Gastroenterology/IBD. A successful candidate should have a deep understanding of mucosal immunology, and will lead a team of discovery scientists within the broader Gastroenterology team focused primarily on delivering novel therapeutics from target identification through preclinical development and first-in-human studies. A deep understanding of establishing and validating novel disease-relevant translational endpoints, both immune and non-immune, in drug development as well as a proven track record of delivering drug candidates to various stages within the discovery pipeline are essential. Candidates should also be able to demonstrate their ability to work cross-functionally in matrixed teams including management of collaborative external partnerships to advance innovative, patient-centric discovery programs. This role requires strong scientific, people leadership, and strategic thinking. The individual will: Integrate emerging scientific trends, patient-derived data, and utilization of humanized complex in vitro models (CIVMs) to identify/validate novel therapeutic targets for the treatment of IBD. Demonstrate exceptional strategic thinking by developing and executing robust research and drug discovery strategies that align with organizational objectives and drive innovation in autoimmune disease research. Provide scientific guidance and set direction for assay development, risk management, and research productivity. Ensure high-quality experimental design, incorporating early risk assessments and contingency planning. Foster cross-functional engagement across internal and external groups, including Chemistry, Biotherapeutics, Genetic Medicine, Precision Medicine, Clinical Development, and outside collaborations. Demonstrates exceptional ability to lead within a highly matrixed environment, effectively managing a team engaged across multiple programs and projects Actively participate in shaping overall disease area and target identification strategies, impacting the research group’s long-term vision and priorities. Communicate research progress and scientific direction to executive stakeholders. Champion mentorship and inclusive team culture, upholding AbbVie’s corporate standards. An ideal candidate will have a background in mucosal immunology including both immune and non-immune cells and a proven track record for leading discovery programs from early-stage conception to clinical candidate selection.
Key Responsibilities
Lead, manage, and develop a high-performing research team, ensuring their professional growth across all career stages. Oversee the planning and execution of in vitro and in vivo pharmacology studies, including the development and application of humanized CIVMs and PKPD assessments. Direct drug discovery programs, driving progression from early-stage conception to clinical candidate selection through strategic leadership and collaboration. Devise and implement research strategies that address critical scientific objectives and adapt to new internal and external scientific trends. Collaborate across multidisciplinary teams and with external research partners to accelerate program advancement. Develop and execute risk